Tagged with MS

Thailand Kevin Peters, Managing Director of MSD in Thailand, highlights the strategic significance and strong performance of the affiliate as a top three pharmaceutical player in Thailand. Kevin goes on to share his mission to position MSD as an innovative partner of Thailand’s healthcare stakeholders in improving the outcomes, access, and…

Sweden Though far from the largest pharma market in Europe, Sweden nevertheless holds strategic importance for global pharma; from the country’s attitude to public health to its sophisticated digital framework, comprehensive patient registries and innovative spirit. Here, four pharma country managers hailing from outside Sweden’s borders give their first impressions of…

Opinion Krishna Cheriath, chief data officer at BMS, outlines the ways in which AI is already transforming the delivery of healthcare, what modern biopharma companies’ AI innovation agendas should include, and why behavioural change is a key tenet in securing meaningful health outcomes with AI.   As Biopharma increases AI investments,…

Puerto Rico Leobardo Hidalgo, who lived in Puerto Rico as a child, recently came back to the island to head commercial operations at the local BMS affiliate, which has been performing remarkably well. He highlights a portfolio of transformational medicines matched with the local team’s patient-centric approach and knowledge of the ecosystem…

Sweden Iddo Leshem, general manager Nordics at Bristol-Myers Squibb (BMS), talks about the uniqueness of Sweden’s collaborative culture and shatters some of the entrenched stereotypes about the country. He then breaks down the drivers behind the outstanding performance of the affiliate and emphasizes the important role Sweden plays in the development…

Logistics In a potentially significant step forward in biopharmaceutical supply chain logistics, a collaboration between AT&T, Direct Relief, MSD and Softbox is testing the potential of drones to deliver temperature-dependent medicines and vaccines to remote locations, most recently flying over open waters while using temperature-stabilizing technology.   The Bahamas test proves…

Sweden Jakob Tellgren recently returned from MSD’s US headquarters to his home country of Sweden to take the helm of the Nordic and Baltic countries. He shares the importance of Sweden and the Nordics for the group and his plans to continue driving the outstanding performance of the affiliate while bringing…

Vaccines MSD’s Cyril Schiever outlines why vaccine hesitancy is such a threat to global health, the misinformation around vaccines being spread online, and how multi-stakeholder collaboration can help counter this emerging problem.   The World Health Organization (WHO) recently identified vaccine hesitancy as one of the top 10 global health threats…

Thailand PharmaBoardroom last reported on Thailand in 2015, meeting country managers from across the healthcare and life sciences value chain. Here, we chart some of their career progressions since then.   Sticking with Servier Guillaume Drianno Guillaume Drianno was Thailand country manager for French firm Servier between 2013 and 2017. Prior…

Sweden The top 50 most sold drugs in Sweden for 2018. AbbVie’s Humira takes the top spot for the second year running, followed by Gilead’s Epclusa and BMS and Pfizer’s Eliquis.   Made with Visme Infographic Maker  

Sweden The Top 20 pharma companies in Sweden ranked by sales in 2018. Out in front is Swiss giant Novartis with approx USD 256 million in sales, followed by MSD with USD 220 million and Pfizer with USD 212 million. The companies with the highest levels of sales growth since 2017…

Europe From her vantage point as associate vice president for MSD’s Central & Eastern Europe (CEE) cluster, Gabriele Grom outlines the disparity that still exists in terms of access to cancer treatments across Europe and what must be done to bridge this gap.   Despite the existence of innovative treatments, cancer…